Načítá se...
Management of Post-transplant Hyperparathyroidism and Bone Disease
Significant advances in immunosuppressive therapies have been made in renal transplantation, leading to increased allograft and patient survival. Despite improvement in overall patient survival, patients continue to require management of persistent post-transplant hyperparathyroidism. Medications th...
Uloženo v:
| Vydáno v: | Drugs |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6439149/ https://ncbi.nlm.nih.gov/pubmed/30811012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01074-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|